CAS 70132-50-2|Pimonidazole
| Common Name | Pimonidazole | ||
|---|---|---|---|
| CAS Number | 70132-50-2 | Molecular Weight | 254.286 |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 490.5±55.0 °C at 760 mmHg |
| Molecular Formula | C11H18N4O3 | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | 250.5±31.5 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 1-(2-nitroimidazol-1-yl)-3-piperidin-1-ylpropan-2-ol |
|---|---|
| Synonym | More Synonyms |
Pimonidazole BiologicalActivity
| Description | Pimonidazole is a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in tumor. Pimonidazole is used for intravenous administration followed by biopsy, it can be used for qualitative and quantitative assessment of tumor hypoxia[1].Pimonidazole accumulates in hypoxic cells via covalent binding with macromolecules or by forming reductive metabolites after reduction of its nitro group[2]. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
| References | [1]. Varia MA, et al. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol. 1998 Nov;71(2):270-7. [2]. Masaki Y, et al. Imaging Mass Spectrometry Revealed the Accumulation Characteristics of the 2-Nitroimidazole-Based Agent "Pimonidazole" in Hypoxia. PLoS One. 2016 Aug 31;11(8):e0161639. |
Chemical & Physical Properties
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 490.5±55.0 °C at 760 mmHg |
| Molecular Formula | C11H18N4O3 |
| Molecular Weight | 254.286 |
| Flash Point | 250.5±31.5 °C |
| Exact Mass | 254.137894 |
| PSA | 87.11000 |
| LogP | 1.00 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.642 |
| InChIKey | WVWOOAYQYLJEFD-UHFFFAOYSA-N |
| SMILES | O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1 |
| Storage condition | 2-8°C |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Hazard Codes | Xn |
| RIDADR | NONH for all modes of transport |
Articles34
More Articles| Loss of the Notch effector RBPJ promotes tumorigenesis. J. Exp. Med. 212(1) , 37-52, (2015) Aberrant Notch activity is oncogenic in several malignancies, but it is unclear how expression or function of downstream elements in the Notch pathway affects tumor growth. Transcriptional regulation ... | |
| Right Ventricular Angiogenesis is an Early Adaptive Response to Chronic Hypoxia-Induced Pulmonary Hypertension. Microcirculation 22 , 724-736, (2016) Myocardial angiogenesis is presumed to play a role in RV adaptation to PH, though definitive evidence and functional correlations are lacking. We aimed to use definitive methods to correlate RV angiog... | |
| Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling. Oncotarget 5(20) , 9664-77, (2014) Hypoxia is a common phenomenon occurring in the majority of human tumors and has been proved to play an important role in tumor progression. However, it remains unclear that whether the action of hypo... |
Synonyms
| 1-Piperidineethanol, α-[(2-nitro-1H-imidazol-1-yl)methyl]- |
| Pimonidazol |
| (±)-a-[(2-nitro-1H-imidazol-1-yl)methyl]-1-piperidineethanol |
| UNII:46JO4D76R2 |
| Pimonidazole [INN:BAN] |
| Pimonidazole |
| Pimonidazol [Spanish] |
| 1-(2-nitro-imidazol-1-yl)-3-piperidin-1-yl-propan-2-ol |
| 1-(2-Nitro-1H-imidazol-1-yl)-3-(1-piperidinyl)-2-propanol |
| (±)-α-((2-Nitroimidazol-1-yl)methyl)-1-piperidineethanol |
| 1-(2-nitroimidazol-1-yl)-3-(1-piperidinyl)-2-propanol |
| 1-(2-Nitro-1H-imidazol-1-yl)-3-(piperidin-1-yl)propan-2-ol |
| Pimonidazolum |
| Ro 03-8799 |
| Pimonidazolum [Latin] |
